Matrixx Initiatives Inc

FDA Regulatory Profile

Matrixx Initiatives Inc appears in FDA public data with 1 recall — including 1 Class I (most serious) —, 0 510(k) clearances, 5 FDA inspections, and 2 compliance actions on record. Its most recent recall (D-155-2013, Class I) was initiated on December 18, 2012.

Summary

Total Recalls
1 (1 Class I)
510(k) Clearances
0
Inspections
5
Compliance Actions
2

Recent Recalls

NumberClassProductDate
D-155-2013Class IZicam Extreme Congestion Relief (oxymetazoline HCl) nasal gel, 0.05%, 0.50 fl. oz. (15 mL) spray botDecember 18, 2012